C07D 457/06
Lysergic acid amides
C07D457/06 (Lysergic acid amides) appears on 81 US grants and 73 published applications in this corpus.
Search patents in C07D- Granted patents
- 81
- Published applications
- 73
- Assignees
- 43
- Inventors
- 225
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 3 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 6 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 1 |
| 2002 | 1 | 2 |
| 2003 | 1 | 6 |
| 2004 | 5 | 2 |
| 2005 | 0 | 3 |
| 2006 | 2 | 5 |
| 2007 | 4 | 2 |
| 2008 | 1 | 0 |
| 2009 | 2 | 2 |
| 2010 | 2 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 1 |
| 2014 | 2 | 1 |
| 2015 | 1 | 4 |
| 2016 | 0 | 4 |
| 2017 | 4 | 1 |
| 2018 | 1 | 3 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 4 |
| 2022 | 0 | 2 |
| 2023 | 3 | 9 |
| 2024 | 2 | 6 |
| 2025 | 4 | 5 |
| 2026 | 3 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Composition and method for treating metabolic disorders30 Jun 2026US 12,668,590 B2VeroScience LLC
- Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic/psychotomimetic dosages and formulations5 May 2026US 12,616,706 B2Arbormentis LLC
- LSD salt crystal forms27 Jan 2026US 12,534,460 B2Mind Medicine, Inc.
- Composition and method for treating metabolic disorders9 Dec 2025US 12,492,198 B2VeroScience LLC
- LSD derivatives, synthesis and method for treatment of diseases and disorders17 Jun 2025US 12,331,051 B2Betterlife Pharma Inc.
- Composition and Method for Treating Metabolic Disorders17 Sep 2026US 2026/0274834 A1VeroScience LLC
- Lipid prodrugs of bromolysergide and uses thereof20 Aug 2026US 2026/0242371 A1Seaport Therapeutics, Inc.
- Compositions and methods of use comprising substances with neural plasticity actions administered at non-psychedelic / psychotomimetic dosages and formulations13 Aug 2026US 2026/0232704 A1Arbormentis LLC
- Lsd salt crystal forms23 Jul 2026US 2026/0209229 A1Definium Therapeutics US, Inc.
- Isotopically enriched analogs of 2-bromo-lsd, lsd, ald-52, and 1p-lsd2 Apr 2026US 2026/0092060 A1
Most cited
By later US patents
- Ergoline derivatives48US 7,666,877 B2Novartis AG · 2010
- Compostions and methods for preventing and/or treating disorders associated with cephalic pain39US 8,859,579 B22014
- Ergoline derivatives and their use as somatostatin receptor antagonists34US 6,221,870 B1Novartis AG · 2001
- Dimethylaminoalkyl-3-(ergoline-8'.beta.carbonyl)-ureas30US 4,526,892 AFarmitalia Carlo Erba S.p.A. · 1985
- 8-pyridazinylcarbamoyl ergolines29US 4,675,404 AFarmitala Carlo Erba S.p.A. · 1987